Welcome to LookChem.com Sign In|Join Free

CAS

  • or

55052-25-0

Post Buying Request

55052-25-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

55052-25-0 Usage

Synonyms

N-acetyl-6-acetoxy-7-azaindole

Molecular Weight

235.24 g/mol

Structure

A derivative of the heterocyclic compound indole

Pharmaceutical Applications

Widely used in the synthesis of various drugs and natural products

Pharmacological Properties

Potential antiproliferative and antitumor activities in cancer cells

Additional Effects

Investigated for anti-inflammatory and analgesic properties

Therapeutic Applications

Shows promise as a versatile compound with potential therapeutic applications in various medical fields

Check Digit Verification of cas no

The CAS Registry Mumber 55052-25-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,0,5 and 2 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 55052-25:
(7*5)+(6*5)+(5*0)+(4*5)+(3*2)+(2*2)+(1*5)=100
100 % 10 = 0
So 55052-25-0 is a valid CAS Registry Number.

55052-25-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (1-acetylpyrrolo[2,3-b]pyridin-6-yl) acetate

1.2 Other means of identification

Product number -
Other names acetic acid 1-acetyl-1H-pyrrolo[2,3-b]pyridin-6-yl ester

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:55052-25-0 SDS

55052-25-0Relevant articles and documents

MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES

-

, (2021/11/06)

The present disclosure relates to novel compounds for use in therapeutic treatement of a disease associated with peptidylarginine deiminases (PADs), such as peptidylarginine deiminase type 4 (PAD4). The present disclosure also relates to processes and intermediates for the preparation of such compounds, methods of using such compounds and pharmaceutical compositions comprising the compounds described herein.

AZAINDOLE DERIVATIVE HAVING PGD2 RECEPTOR ANTAGONISTIC ACTIVITY

-

Page/Page column 34, (2008/06/13)

The present invention creates an azaindole derivative having DP receptor antagonistic activity and a pharmaceutical composition comprising the said compound as an active ingredient, and further providing a therapeutic agent for treating allergic diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 55052-25-0